Is a complete ETR/MED research report available?

No complete published report is available for etr/MED (ETR/MED) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

etr/MED stock profile: metrics, valuation and analysis

Market cap	261.3M
Revenue (ttm)	819.8M
Net income (ttm)	29.1M
EPS (ttm)	€0.61
Shares out	47.5M
P/E (trailing)	9.0x
P/E (forward)	7.1x
Dividend	€0.04 (0.73%)
Volume	19
Beta	0.43

All ETR/MED indicators

Market & fundamental data

Available fields

242

Groups with data

Currency

EUR

Showing 242 of 242 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Germany
Country code	DE
Employees	7,048
Employees Change	107%
Employees Change Percent	1.54
Enterprise value	EUR 566.9M
Exchange	Deutsche Börse Xetra
Financial currency	EUR
First seen	2026-05-10
Industry	Medical Care Facilities
Industry PE	14.49
Industry PE Fwd	11.21
Isin	DE0006595101
Last refreshed	2026-09-06
Market cap	EUR 261.3M
Price	EUR 5.5
Price currency	EUR
Rev Per Employee	116,322.32x
Sector	Healthcare
Sector PE	38.15
Sector PE Fwd	14.39
Sic	8093
Symbol	etr/MED
Website	https://www.mediclin.de

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	11.14%
EV Earnings	19.47x
EV/EBIT	8.79x
EV/EBITDA	4.81x
EV/FCF	10.13x
EV/Sales	0.69x
FCF yield	21.42%
Forward P/E	7.14x
P/B ratio	1x
P/E ratio	8.97x
P/S ratio	0.32x
PE Ratio10 Y	62.66x
PE Ratio3 Y	5.48x
PE Ratio5 Y	17.6x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	7.86%
EBITDA Margin	10.72%
FCF margin	6.83%
Gross margin	20.92%
Gross Profit	EUR 171.5M
Gross Profit Growth	7.14%
Gross Profit Growth Q	-0.28%
Gross Profit Growth3 Y	10.33%
Gross Profit Growth5 Y	10.51%
Net Income	EUR 29.1M
Net Income Growth	-14.27%
Net Income Growth Q	-0.68%
Net Income Growth Qo Q	178.01%
Net Income Growth Years	2%
Net Income Growth3 Y	34.71%
Pretax Margin	4.96%
Profit Margin	3.55%
Profit Per Employee	EUR 4,130
Profitable Quarters	EUR 5
Profitable Years	2
ROA	4.61
Roa5y	2.33
ROCE	9.55
ROE	11.93
Roe5y	4.67
ROIC	8.28
Roic5y	4.79

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-0.1%
Cagr15y	2.96%
Cagr1y	85.37%
Cagr20y	2.06%
Cagr3y	24.49%
Cagr5y	7.97%
Div CAGR10	-2.21%
Div CAGR3	0%
Div CAGR5	-4.36%
EPS Growth	-13.68
EPS Growth Qo Q	200
EPS Growth Quarters	2
EPS Growth Years	2
EPS Growth3 Y	34.84
FCF Growth	11.21%
FCF Growth Q	77.2%
FCF Growth Qo Q	200.69%
FCF Growth3 Y	48.03%
FCF Growth5 Y	-2.93%
OCF Growth	4.92%
OCF Growth Q	8.37%
OCF Growth Qo Q	77.66%
OCF Growth10 Y	11.52%
OCF Growth3 Y	26.65%
OCF Growth5 Y	3.63%
Revenue Growth	6.22x
Revenue Growth Q	4.68x
Revenue Growth Qo Q	5.5x
Revenue Growth Quarters	5x
Revenue Growth Years	5x
Revenue Growth3 Y	3.76x
Revenue Growth5 Y	4.36x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.94
Assets	EUR 844.2M
Cash	EUR 77.4M
Current Assets	EUR 299.9M
Current Liabilities	EUR 169.2M
Debt	EUR 382.4M
Debt EBITDA	EUR 3.25
Debt Equity	EUR 1.47
Debt FCF	EUR 6.83
Equity	EUR 260.3M
Interest Coverage	3.32
Liabilities	EUR 584M
Long Term Assets	EUR 544.3M
Long Term Liabilities	EUR 414.8M
Net Cash	EUR -305M
Net Cash By Market Cap	EUR -117
Net Debt EBITDA	EUR 3.47
Net Debt Equity	EUR 1.17
Net Debt FCF	EUR 5.45
Tangible Book Value	EUR 242M
Tangible Book Value Per Share	EUR 5.1
WACC	4.87

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.77
Inventory Turnover	100.7
Net Working Capital	EUR 82.2M
Quick ratio	1.09
Working Capital	EUR 130.7M
Working Capital Turnover	EUR 6.15

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	EUR 0.04
Dividend Years	2
Dividend Yield	0.73%
Ex Div Date	2026-05-29
Last Dividend	EUR 0.04
Payout Ratio	6.53%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-0.96%
1Y total return	85.29%
200-day SMA	3.91
3Y total return	92.98%
50-day SMA	4.53
50-day SMA vs 200-day SMA	50over200
5Y total return	46.74%
All Time High	15.18
All Time High Change	-63.77%
All Time High Date	2001-01-02
All Time Low	0.98
All Time Low Change	461.22%
All Time Low Date	2002-10-07
ATR	0.17
Beta	0.43
Beta1y	0.41
Beta2y	0.3
Ch YTD	48.65
High	5.5
High52	5.6
High52 Date	2026-09-01
High52ch	-1.79%
Low	5.35
Low52	2.88
Low52 Date	2025-09-04
Low52ch	90.97%
Ma50ch	21.39%
Price vs 200-day SMA	40.74%
RSI	78.24
RSI Monthly	78.94
RSI Weekly	80.74
Sharpe ratio	1.81x
Sharpe Ratio3y	0.67x
Sharpe Ratio5y	0.27x
Sortino ratio	3.16
Sortino Ratio3y	1.3
Sortino Ratio5y	0.64
Total Return	0.73%
Tr YTD	50.24
Tr15y	54.96%
Tr1m	34.15%
Tr3m	32.21%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	11,438,997%
Net Borrowing	-77,680,359
Shares Institutions	36.18%
Shares Out	47,500,000
Shares Qo Q	-1.65%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	10,829.85x
Bv Per Share	5.46
CAPEX	EUR -42M
Ch10y	-4.99
Ch15y	48.65
Ch1m	34.15
Ch1y	83.33
Ch20y	37.5
Ch3m	32.21
Ch3y	88.36
Ch5y	43.23
Ch6m	46.28
Change	0%
Change From Open	2.8
Close	5.5
Days Gap	-2.73
Depreciation Amortization	23,430,111
Dollar Volume	104.5
Earnings Date	2026-11-05
EBIT	EUR 64.4M
EBITDA	EUR 87.9M
EPS	EUR 0.61
F Score	7
FCF	EUR 56M
FCF EV Yield	9.87x
FCF Per Share	EUR 1.18
Financing CF	-99,068,240
Fiscal Year End	December
Founded	1,994
Goodwill	8,835,610
Graham Number	8.68042
Graham Upside	57.83
Income Tax	EUR 11.3M
Investing CF	-20,738,398
Is Primary Listing	1
Last Earnings Date	2026-07-30
Last Report Date	2026-06-30
Lynch Fair Value	EUR 15.32
Lynch Upside	178.6
Ma150	3.98
Ma150ch	38.26%
Ma20	5.16
Ma20ch	6.67%
Net CF	-21,863,252
Next Earnings Date	2026-11-05
Open	5.35
P FCF Ratio	4.67
P OCF Ratio	2.67
Payment Date	2026-06-02
Position In Range	100
Ppne	496,956,231
Price Date	2026-09-04
Price EBITDA	EUR 2.97
Ptbv Ratio	1.08
Relative Volume	0x
Revenue	819,839,692x
Tax By Revenue	1.38x
Tax Rate	27.74%
Tr20y	50.2%
Tr6m	47.84%
Volume	19
Z Score	1.72

ETR/MED (ETR/MED)

Price

Financial snapshot

Fair-value bridge

Latest news · ETR/MED

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ETR/MED indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on ETR/MED

Frequently asked questions